Internal Medicine, Gastroenterology · Forest City, NC
NPI
1033206461
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
181 Daniel Rd
Forest City, NC, 28043
Phone (828) 286-9036
Groups this clinician bills Medicare through
Medicare paid, 2024
$71K
872 services
Medicare patients, 2024
407
Average age 72
Drug cost, 2024
$1.7M
1,217 prescriptions
Company payments, 2025
$70.47
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen J Melson was code G0500 (moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito), 178 times for 173 patients. In total Stephen J Melson billed 872 services in 34 codes, and Medicare paid $71K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-15.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 178 | 173 | $3.95 | $703 |
| 45385 Colonoscopy - Lesion Removal | Facility | 109 | 108 | $193.77 | $21K |
| 99213 Office E&M - Established | Office | 85 | 76 | $60.12 | $5,110 |
| 43239 Upper GI Endoscopy | Facility | 71 | 69 | $56.30 | $3,997 |
| 99214 Office E&M - Established | Office | 59 | 51 | $84.09 | $4,961 |
| 43235 Upper GI Endoscopy | Facility | 58 | 58 | $64.96 | $3,768 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 50 | 50 | $174.34 | $8,717 |
| 43249 Upper GI Endoscopy | Facility | 45 | 45 | $78.06 | $3,513 |
| 45378 Lower GI Endoscopy - Other | Facility | 34 | 34 | $107.67 | $3,661 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 26 | 26 | $172.62 | $4,488 |
| 45384 Colonoscopy - Lesion Removal | Facility | 25 | 25 | $75.71 | $1,893 |
| 45380 Lower GI Endoscopy - Other | Facility | 24 | 24 | $88.60 | $2,126 |
| 99203 Office E&M - New | Office | 21 | 21 | $63.55 | $1,335 |
| 85027 Blood Count | Office | 17 | 12 | $5.75 | $97.76 |
| 99204 Office E&M - New | Office | 11 | 11 | $130.21 | $1,432 |
By year: 2022 $93K for 1,176 services; 2023 $96K for 967 services; 2024 $71K for 872 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85027 Blood Count | 17 | 12 | $5.75 | $97.76 |
Medicare prescription drug claims, 2024
In 2024, the drug Stephen J Melson prescribed most often to Medicare patients was Pantoprazole Sodium, with 385 prescriptions and refills. In total Stephen J Melson wrote 1,217 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 385 | 715 | 109 | $3,204 |
| Famotidine Generic | 170 | 273 | 40 | $1,416 |
| Dicyclomine Hcl Generic | 66 | 94 | 14 | $1,352 |
| Mesalamine Generic | 44 | 58 | Under 11 | $14K |
| Linzess Linaclotide | 40 | 66 | Under 11 | $35K |
| Metoclopramide Hcl Generic | 39 | 39 | Under 11 | $253 |
| Esomeprazole Magnesium Generic | 33 | 54 | Under 11 | $897 |
| Humira(Cf) Pen Adalimumab | 29 | 29 | Under 11 | $283K |
| Humira Adalimumab | 26 | 26 | Under 11 | $357K |
| Stelara Ustekinumab | 22 | 41 | Under 11 | $616K |
| Omeprazole Generic | 22 | 56 | Under 11 | $268 |
| Mesalamine Er Mesalamine | 22 | 39 | Under 11 | $3,081 |
| Sucralfate Generic | 21 | 34 | Under 11 | $1,297 |
| Prednisone Generic | 20 | 20 | Under 11 | $101 |
| Lansoprazole Generic | 20 | 36 | Under 11 | $429 |
Brand drugs: 194 claims; generic drugs: 1,023 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen J Melson $70.47 ($70.47 in general payments such as food, travel and fees) from 3 companies. The largest payer was Abbvie Inc. with $29.62.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.